glp-1 weight loss telehealth Claya launches Platform for Medications GLP-1 Overdoses Are Rising as
Description
Neuroreport, 27, 992996
Clinicians should counsel patients that while preclinical data appear promising, cognitive enhancement remains an investigational application requiring further study
For more information, visit www.wellgisticshealth.com
With all the expanding possible indications, the GLP-1 peptides are being prescribed off-label for many purposes, and now people are microdosing the drugs despite the lack of data
Diabetes Care, 19992010, The New England journal of medicine, 369 (2013) 287288
